Applied Filters
Fed Circ grants Arthrex remand, rejects Iancu conflict
The US Court of Appeals for the Federal Circuit granted the owner of an artificial heart valve patent a remand under Arthrex, but shot down the company’s attempt to escape an inter partes review by citing a conflict.
Cochlear to pay $75m extra if patent judgment upheld
Hearing implant manufacturer Cochlear has agreed to pay an additional $75 million to settle a patent infringement case if an original $268 million damages bill is upheld by the US Supreme Court.
3M wins $200k face mask settlement
An Amazon seller has agreed to pay almost $200,000 to settle a trademark lawsuit brought by face mask manufacturer 3M over alleged price gouging.
Fed Circuit throws out doctors’ patent suit
The US Court of Appeals for the Federal Circuit has thrown out a patent infringement lawsuit brought by two Illinois doctors against more than 300 hospitals.
Medit scores win in 3Shape patent battle
South Korean medical devices manufacturer Medit has prevailed in a patent infringement lawsuit brought by Danish rival 3Shape in Germany.
J&J wants $25m over ‘contaminated’ fake medical tools
Johnson & Johnson has accused a medical supplier of distributing counterfeit surgical tools that are “bacterially contaminated and critically defective”.
3M secures settlements in price-gouging litigation
3M has settled with two companies it had accused of reselling N95 masks at inflated prices amid the COVID-19 pandemic.
Roche accuses competitor of infringing diabetes patent
Roche Diabetes Care, a subsidiary of Switzerland-based Roche, has accused medical device company Insulet of infringing a patent covering a blood glucose level monitor.
MicroPort accuses rival of selling ‘knock-off’ surgical tools
MicroPort Orthopedics has sued rival Medacta, accusing it of providing surgeons with “knock-off copies and defaced versions” of MicroPort’s patented surgical tools.
Illumina secures injunction against BGI
Genetic sequencing company Illumina has obtained a preliminary injunction against its China-based rival BGI.
